Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis

References

• TripathiDHayesPCThe role of carvedilol in the management of portal hypertensionEur J Gastroenterol Hepatol201022890591120093937
   PubMed Web of Science ®Google Scholar
• Garcia-TsaoGAbraldesJGBerzigottiABoschJPortal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver DiseasesHepatology201765131033527786365
   PubMed Web of Science ®Google Scholar
• YangLHanGHRevising consensus in portal hypertension: report of the Baveno V consensus workshopJ Clin Hepatol2011272116118
   Google Scholar
• KirnakeVAroraAGuptaVHemodynamic response to carvedilol is maintained for long periods and leads to better clinical outcome in cirrhosis: a prospective studyJ Clin Exp Hepatol20166317518527746613
   PubMedGoogle Scholar
• KimHYJungYJSoYHWooHKimWNoninvasive prediction of hemodynamic response to carvedilol therapy for primary prophylaxis in cirrhotic patients with esophageal varices: a prospective studyJ Hepatol2017661S47
   Web of Science ®Google Scholar
• TripathiDTherapondosGLuiHFStanleyAJHayesPCHaemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertensionAliment Pharmacol Ther200216337338011876689
   PubMed Web of Science ®Google Scholar
• SilkauskaitėVKupčinskasJPranculisAJonaitisLPetrenkienėVKupčinskasLAcute and 14-day hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosisMedicina2013491173
   Web of Science ®Google Scholar
• SinagraEPerriconeGD’AmicoMTinèFD’AmicoGSystematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosisAliment Pharmacol Ther201439655756824461301
   PubMed Web of Science ®Google Scholar
• GluudLLKragABanding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.Cochrane Database Syst Rev20128CD004544
   PubMed Web of Science ®Google Scholar
• Garcia-PagánJCBoschJEndoscopic band ligation in the treatment of portal hypertensionNat Clin Pract Gastroenterol Hepatol200521152653516355158
   PubMedGoogle Scholar
• HigginsJPTGreenSCochrane Handbook for systematic reviews for interventionsCochrane Database Syst Rev2008 Available from: https://www.radioterapiaitalia.it/wp-content/uploads/2017/01/cochrane-handbook-for-systematic-reviews-of-interventions.pdfAccessed January 21, 2019
   Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• ElnadryMHAbdel-AzizIMElshaffeeAMEndoscopic band ligation versus carvedilol for primary prevention of bleeding esophageal varices clinical.Biochemical and Doppler Ultrasonographic Evaluation2010 Available from: http://www.aamj.eg.net/journals/pdf/1267.pdfAccessed January 21, 2019
   Google Scholar
• MaharajSSeegobinKPerez-DownesJBajricBChangSReddyPSevere carvedilol toxicity without overdose – caution in cirrhosisClin Hypertens20172312529214053
   PubMedGoogle Scholar
• TiniakosDGPapatheodoridisGVSerum markers of hepatocyte apoptosis: current terminology and predictability in clinical practiceHepatology201051271771819918977
   PubMed Web of Science ®Google Scholar
• ReibergerTUlbrichGFerlitschACarvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranololGut201362111634164123250049
   PubMed Web of Science ®Google Scholar
• ShahHAAzamZRaufJCarvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trialJ Hepatol201460475776424291366
   PubMed Web of Science ®Google Scholar
• Abd ElrahimAYFouadRKhairyMEfficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleedingHepatol Int2018121758229185106
   PubMed Web of Science ®Google Scholar
• AhmadMSamyEAal EmanAHosamDEvaluation of carvedilol in prevention of first attack of variceal hemorrhage in patients with liver cirrhosisAfro-Egyptian Journal of Infectious and Endemic Diseases2012228791
   Google Scholar
• StanleyAJDicksonSHayesPCMulticentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleedingJ Hepatol20146151014101924953021
   PubMed Web of Science ®Google Scholar
• TripathiDFergusonJWKocharNRandomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleedHepatology200950382583319610055
   PubMed Web of Science ®Google Scholar
• SchepkeMDrugsSMDrugs, ligation or both for the prevention of variceal rebleeding?Gut20095881045104619592688
   PubMed Web of Science ®Google Scholar
• Garcia-PaganJCde GottardiABoschJReview article: the modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patientsAliment Pharm Ther2008282178186
   PubMed Web of Science ®Google Scholar
• LiLYuCLiYEndoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysisCan J Gastroenterol201125314715521499579
   PubMed Web of Science ®Google Scholar
• FunakoshiNDunyYValatsJCMeta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleedingAnn Hepatol201211336938322481457
   PubMed Web of Science ®Google Scholar
• VorobioffJPicabeaEVillavicencioRAcute and chronic hemodynamic effects of propranolol in unselected cirrhotic patientsHepatology1987746486533610045
   PubMed Web of Science ®Google Scholar
• RoloAPOliveiraPJMorenoAJPalmeiraCMChenodeoxycholate induction of mitochondrial permeability transition pore is associated with increased membrane fluidity and cytochrome c release: protective role of carvedilolMitochondrion20032430531116120330
   PubMed Web of Science ®Google Scholar
• BakrisGLFonsecaVKatholiREMetabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trialJAMA2004292182227223615536109
   PubMed Web of Science ®Google Scholar
• AkbasHOzdenMKankoMProtective antioxidant effects of carvedilol in a rat model of ischaemia-reperfusion injuryJ Int Med Res200533552853616222886
   PubMed Web of Science ®Google Scholar
• SinhaRLockmanKAMallawaarachchiNRobertsonMPlevrisJNHayesPCCarvedilol use is associated with improved survival in patients with liver cirrhosis and ascitesJ Hepatol2017671404628213164
   PubMed Web of Science ®Google Scholar